We are live on ! Find out more
LDRS

Innovator IBD ETF Leaders ETF

Delisted

LDRS was delisted on the 13th of August, 2021.

5 hedge funds and large institutions have $1.52M invested in Innovator IBD ETF Leaders ETF in 2017 Q4 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
+5
Holders Change %
% of All Funds
0.11%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
FAIM
1
Financial Advocates Investment Management
Washington
$638K +$1.26M +49,532 New
VF
2
Virtu Financial
New York
$632K +$628K +24,732 New
LTFS
3
Ladenburg Thalmann Financial Services
Florida
$230K +$229K +9,000 New
AF
4
Advisornet Financial
Minnesota
$15K +$15.2K +600 New
Royal Bank of Canada
5
Royal Bank of Canada
Ontario, Canada
$7K +$6.98K +275 New

LDRS Hedge Fund Activity: Q4 2017 in Review

5 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Innovator IBD ETF Leaders ETF (LDRS) for Q4 2017, worth a combined $1.52M.

Buyers outnumbered sellers: 5 funds opened new LDRS positions and 0 closed out — a net gain of 5 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Virtu Financial, opening a new position worth an estimated $628K.

  • 5 institutional investors held Innovator IBD ETF Leaders ETF (LDRS) as of Q4 2017, up from 0 in Q3 2017.
  • Funds reported $1.52M of Innovator IBD ETF Leaders ETF stock for Q4 2017.
  • 5 funds opened new Innovator IBD ETF Leaders ETF positions in Q4 2017 and 0 closed out, a net change of +5 holders.
  • The largest Innovator IBD ETF Leaders ETF buyer in Q4 2017 was Virtu Financial, an estimated $628K added.

Based on aggregated 13F filings for Q4 2017.